Perioperative Anaphylaxis

Immunology and Allergy Clinics of North America

Volumn 29, Issue 3, 2009, Pages 429-451

  Mertes, P M ^a,b   Lambert, M ^a,b   Gueant Rodriguez R M ^b,c   Aimone Gastin, I ^b,c   Mouton Faivre, C ^a   Moneret Vautrin, D A ^a   Gueant J L ^b,c   Malinovsky, J M ^d   Demoly, P ^e  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b INSERM   (France)

^c CHU NANCY BRABOIS   (France)

^d REIMS UNIVERSITY HOSPITAL   (France)

^e HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Allergy; Anaphylaxis; Anesthesia; IgE; Neuromuscular blocking agent; Skin test

Indexed keywords

ANTIBIOTIC AGENT; APROTININ; BUPIVACAINE; CHLORHEXIDINE; CODEINE PHOSPHATE; CORTICOSTEROID; CREMOPHOR; DISULFINE BLUE; FENTANYL; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN E; ISOSULFAN BLUE; LATEX; LEVOBUPIVACAINE; LIDOCAINE; MEPIVACAINE; MORPHINE; NEUROMUSCULAR BLOCKING AGENT; OPIATE; PANCURONIUM; PETHIDINE; PRILOCAINE; ROPIVACAINE; SUXAMETHONIUM; THIOPENTAL; TRYPTASE; UNINDEXED DRUG;

ALLERGY; ANAPHYLAXIS; ANESTHESIA INDUCTION; ANTIBODY DETECTION; BASOPHIL; CELL ASSAY; CLINICAL EXAMINATION; CLINICAL FEATURE; COLLOID; CROSS REACTION; DRUG HYPERSENSITIVITY; ENZYME ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HISTAMINE RELEASE; HUMAN; IMMUNE RESPONSE; INCIDENCE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; PROVOCATION TEST; RADIOIMMUNOASSAY; REVIEW; RISK ASSESSMENT; SKIN TEST;

ALLERGENS; ANAPHYLAXIS; ANESTHESIA, GENERAL; ANTI-BACTERIAL AGENTS; BASOPHIL DEGRANULATION TEST; DRUG HYPERSENSITIVITY; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; INCIDENCE; INTRAOPERATIVE COMPLICATIONS; LATEX; LATEX HYPERSENSITIVITY; NEUROMUSCULAR BLOCKING AGENTS; PERIOPERATIVE CARE; TRYPTASES;

EID: 67649219130     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2009.04.004     Document Type: Review

References (112)

1. Lienhart A., Auroy Y., Pequignot F., et al. Survey of anesthesia-related mortality in France. Anesthesiology 105 6 (2006) 1087-1097
2. Mertes P.M., Laxenaire M.C., Lienhart A., et al. Reducing the risk of anaphylaxis during anaesthesia: guidelines for clinical practice. J Investig Allergol Clin Immunol 15 2 (2005) 91-101
3. Johansson S.G., Bieber T., Dahl R., et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, 2003. J Allergy Clin Immunol 113 5 (2004) 832-836
4. Laxenaire M.C. [What is the real risk of drug hypersensitivity in anesthesia? Incidence. Clinical aspects. Morbidity-mortality. Substances responsible]. Ann Fr Anesth Reanim 21 Suppl 1 (2002) 38s-54s [in French]
5. Fisher M.M., and More D.G. The epidemiology and clinical features of anaphylactic reactions in anaesthesia. Anaesth Intensive Care 9 3 (1981) 226-234
6. Mertes P.M., and Laxenaire M.C. Allergic reactions occurring during anaesthesia. Eur J Anaesthesiol 19 (2002) 240-262
7. Watkins J. Adverse anaesthetic reactions: an update from a proposed national reporting and advisory service. Anaesthesia 40 8 (1985) 797-800
8. Thienthong S., Hintong T., and Pulnitiporn A. The Thai Anesthesia Incidents Study (THAI Study) of perioperative allergic reactions. J Med Assoc Thai 88 Suppl 7 (2005) S128-S133
9. Whittington T., and Fisher M.M. Anaphylactic and anaphylactoid reactions: clinical anaesthesiology. Baillieres Clin Anaesthesiol 12 (1998) 301-323
10. Laxenaire M.C. Epidémiologie des réactions anaphylactoïdes peranesthésiques. Quatrième enquête multicentrique (juillet 1994-décembre 1996). Ann Fr Anesth Reanim 18 (1999) 796-809 [in French]
11. Escolano F., Valero A., Huguet J., et al. [Prospective epidemiologic study of perioperative anaphylactoid reactions occurring in Catalonia (1996-7)]. Rev Esp Anestesiol Reanim 49 6 (2002) 286-293 [in Spanish]
12. Harboe T., Guttormsen A.B., Irgens A., et al. Anaphylaxis during anesthesia in Norway: a 6-year single-center follow-up study. Anesthesiology 102 5 (2005) 897-903
13. Fisher M., and Baldo B.A. Anaphylaxis during anaesthesia: current aspects of diagnosis and prevention. Eur J Anaesthesiol 11 4 (1994) 263-284
14. Laxenaire M., Mertes P.M., and GERAP. Anaphylaxis during anaesthesia: results of a 2 year survey in France. Br J Anaesth 21 1 (2001) 549-558
15. Mertes P.M., Alla F., and Laxenaire M.C. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 99 (2003) 536-545
16. Mertes P.M., and Laxenaire M.C. [Anaphylactic and anaphylactoid reactions occurring during anaesthesia in France: seventh epidemiologic survey (January 2001-December 2002)]. Ann Fr Anesth Reanim 23 12 (2004) 1133-1143 [in French]
17. Mitsuhata H., Matsumoto S., and Hasegawa J. [The epidemiology and clinical features of anaphylactic and anaphylactoid reactions in the perioperative period in Japan]. Masui 41 (1992) 1664-1669 [in Japanese]
18. Light K.P., Lovell A.T., Butt H., et al. Adverse effects of neuromuscular blocking agents based on yellow card reporting in the UK: are there differences between males and females?. Pharmacoepidemiol Drug Saf 15 3 (2006) 151-160
19. Baldo B, Fisher M, Pham N. On the origin and specificity of antibodies to neuromuscular blocking (muscle relaxant) drugs. An immunochemical perspective. Clin Exp Allergy 2009;39(3):325-44.
20. Pichler W.J. T cells in drug allergy. Curr Allergy Asthma Rep 2 1 (2002) 9-15
21. Aubert N., Mertes P.M., Janaszak M., et al. Dendritic cells present neuromuscular blocking agent-related epitopes to T cells from allergic patients. Allergy 59 9 (2004) 1022-1023
22. Baldo B.A., and Fisher M.M. Substituted ammonium ions as allergenic determinants in drug allergy. Nature 306 5940 (1983) 262-264
23. Vervloet D., Arnaud A., Senft M., et al. Anaphylactic reactions to suxamethonium: prevention of mediator release by choline. J Allergy Clin Immunol 76 (1985) 222-225
24. Didier A., Cador D., Bongrand P., et al. Role of the quaternary ammonium ion determinants in allergy to muscle relaxants. J Allergy Clin Immunol 79 4 (1987) 578-584
25. Mertes P.M., Aimone-Gastin I., Gueant-Rodriguez R.M., et al. Hypersensitivity reactions to neuromuscular blocking agents. Curr Pharm Des 14 27 (2008) 2809-2825
26. Laxenaire M.C., Gastin I., Moneret-Vautrin D.A., et al. Cross-reactivity of rocuronium with other neuromuscular blocking agents. Eur J Anaesthesiol Suppl 11 (1995) 55-64
27. Galletly D.C., and Treuren B.C. Anaphylactoid reactions during anaesthesia: seven years' experience of intradermal testing. Anaesthesia 40 4 (1985) 329-333
28. Florvaag E., Johansson S.G., Oman H., et al. Prevalence of IgE antibodies to morphine: relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively. Acta Anaesthesiol Scand 49 4 (2005) 437-444
29. Harboe T., Johansson S.G., Florvaag E., et al. Pholcodine exposure raises serum IgE in patients with previous anaphylaxis to neuromuscular blocking agents. Allergy 62 12 (2007) 1445-1450
30. Heier T., and Guttormsen A.B. Anaphylactic reactions during induction of anaesthesia using rocuronium for muscle relaxation: a report including 3 cases. Acta Anaesthesiol Scand 44 7 (2000) 775-781
31. Rose M., and Fisher M. Rocuronium: high risk for anaphylaxis?. Br J Anaesth 86 5 (2001) 678-682
32. Watkins J. Incidence of UK reactions involving rocuronium may simply reflect market use. Br J Anaesth 87 3 (2001) 522
33. Bhananker S.M., O'Donnell J.T., Salemi J.R., et al. The risk of anaphylactic reactions to rocuronium in the United States is comparable to that of vecuronium: an analysis of Food and Drug Administration reporting of adverse events. Anesth Analg 101 3 (2005) 819-822
34. Birnbaum J., and Vervloet D. Allergy to muscle relaxants. Clin Rev Allergy 9 3-4 (1991) 281-293
35. Moss J. Muscle relaxants and histamine release. Acta Anaesthesiol Scand Suppl 106 (1995) 7-12
36. Doenicke A.W., Czeslick E., Moss J., et al. Onset time, endotracheal intubating conditions, and plasma histamine after cis-atracurium and vecuronium administration. Anesth Analg 87 2 (1998) 434-438
37. Jooste E., Klafter F., Hirshman C.A., et al. A mechanism for rapacuronium-induced bronchospasm: M2 muscarinic receptor antagonism. Anesthesiology 98 4 (2003) 906-911
38. Karila C., Brunet-Langot D., Labbez F., et al. Anaphylaxis during anesthesia: results of a 12-year survey at a French pediatric center. Allergy 60 6 (2005) 828-834
39. Niggemann B., and Breiteneder H. Latex allergy in children. Int Arch Allergy Immunol 121 2 (2000) 98-107
40. Hourihane J.O., Allard J.M., Wade A.M., et al. Impact of repeated surgical procedures on the incidence and prevalence of latex allergy: a prospective study of 1263 children. J Pediatr 140 4 (2002) 479-482
41. Moneret-Vautrin D.A., Laxenaire M.C., and Bavoux F. Allergic shock to latex and ethylene oxide during surgery for spinal bifida. Anesthesiology 73 3 (1990) 556-558
42. Renz C.L., Thurn J.D., Finn H.A., et al. Antihistamine prophylaxis permits rapid vancomycin infusion. Crit Care Med 27 9 (1999) 1732-1737
43. Clarke R.S. Epidemiology of adverse reactions in anaesthesia in the United Kingdom. Klin Wochenschr 60 17 (1982) 1003-1005
44. Harle D., Baldo B., and Fisher M. The molecular basis of IgE antibody binding to thiopentone: binding of IgE from thiopentone-allergic and non-allergic subjects. Mol Immunol 27 (1990) 853-858
45. Fisher M., Ross J., Harle D., et al. Anaphylaxis to thiopentone: an unusual outbreak in a single hospital. Anaesth Intensive Care 17 3 (1989) 361-365
46. Fisher M.M., and Bowey C.J. Alleged allergy to local anaesthetics. Anaesth Intensive Care 25 6 (1997) 611-614
47. Ring J., and Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1 8009 (1977) 466-469
48. Laxenaire M.C., Charpentier C., and Feldman L. Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study. Ann Fr Anesth Reanim 13 3 (1994) 301-310
49. Lorenz W., Duda D., Dick W., et al. Incidence and clinical importance of perioperative histamine release: randomised study of volume loading and antihistamines after induction of anaesthesia. Trial Group Mainz/Marburg. Lancet 343 8903 (1994) 933-940
50. Scherer K., Bircher A.J., and Figueiredo V. Blue dyes in medicine-a confusing terminology. Contact Dermatitis 54 4 (2006) 231-232
51. Cimmino V.M., Brown A.C., Szocik J.F., et al. Allergic reactions to isosulfan blue during sentinel node biopsy-a common event. Surgery 130 3 (2001) 439-442
52. Pevny I., and Bohndorf W. [Group allergy due to patent blue sensitization]. Med Klin 67 20 (1972) 698-702 [in German]
53. Wohrl S., Focke M., Hinterhuber G., et al. Near-fatal anaphylaxis to patent blue V. Br J Dermatol 150 5 (2004) 1037-1038
54. Mertes P.M., Malinovsky J.M., Mouton-Faivre C., et al. Anaphylaxis to dyes during the perioperative period: reports of 14 clinical cases. J Allergy Clin Immunol 122 2 (2008) 348-352
55. Keller B., Yawalkar N., Pichler C., et al. Hypersensitivity reaction against patent blue during sentinel lymph node removal in three melanoma patients. Am J Surg 193 1 (2007) 122-124
56. Kober B.J., Scheule A.M., Voth V., et al. Anaphylactic reaction after systemic application of aprotinin triggered by aprotinin-containing fibrin sealant. Anesth Analg 107 2 (2008) 406-409
57. Levy J.H., and Adkinson Jr. N.F. Anaphylaxis during cardiac surgery: implications for clinicians. Anesth Analg 106 2 (2008) 392-403
58. Dietrich W., Ebell A., Busley R., et al. Aprotinin and anaphylaxis: analysis of 12,403 exposures to aprotinin in cardiac surgery. Ann Thorac Surg 84 4 (2007) 1144-1150
59. Garvey L.H., Kroigaard M., Poulsen L.K., et al. IgE-mediated allergy to chlorhexidine. J Allergy Clin Immunol 120 2 (2007) 409-415
60. Nybo M., and Madsen J.S. Serious anaphylactic reactions due to protamine sulfate: a systematic literature review. Basic Clin Pharmacol Toxicol 103 2 (2008) 192-196
61. Kroigaard M., Garvey L.H., Menne T., et al. Allergic reactions in anaesthesia: are suspected causes confirmed on subsequent testing?. Br J Anaesth 95 4 (2005) 468-471
62. Malinovsky J.M., Decagny S., Wessel F., et al. Systematic follow-up increases incidence of anaphylaxis during adverse reactions in anesthetized patients. Acta Anaesthesiol Scand 52 2 (2008) 175-181
63. Laxenaire M.C., Mouton C., Frederic A., et al. Anaphylactic shock after tourniquet removal in orthopedic surgery. Ann Fr Anesth Reanim 15 2 (1996) 179-184
64. Mertes P.M., and Laxenaire M. Anaphylaxis during general anaesthesia: prevention and management. CNS Drugs 14 2 (2000) 115-133
65. Fisher M.M. The preoperative detection of risk of anaphylaxis during anaesthesia. Anaesth Intensive Care 35 6 (2007) 899-902
66. Task Force on Allergic Reaction to Latex. American Academy of Allergy and Immunology committee report. J Allergy Clin Immunol 92 (1993) 16-18
67. Kroigaard M., Garvey L.H., Gillberg L., et al. Scandinavian clinical practice guidelines on the diagnosis, management and follow-up of anaphylaxis during anaesthesia. Acta Anaesthesiol Scand 51 6 (2007) 655-670
68. Mertes P.M., Moneret-Vautrin D.A., Leynadier F., et al. Skin reactions to intradermal neuromuscular blocking agent injections: a randomized multicenter trial in healthy volunteers. Anesthesiology 107 2 (2007) 245-252
69. Ebo D.G., Bridts C.H., Hagendorens M.M., et al. Basophil activation test by flow cytometry: present and future applications in allergology. Cytometry B Clin Cytom 74B 4 (2008) 201-210
70. Laroche D., Lefrancois C., Gerard J.L., et al. Early diagnosis of anaphylactic reactions to neuromuscular blocking drugs. Br J Anaesth 69 6 (1992) 611-614
71. Guttormsen A.B., Johansson S.G., Oman H., et al. No consumption of IgE antibody in serum during allergic drug anaphylaxis. Allergy 62 11 (2007) 1326-1330
72. Mertes P.M., and Laxenaire M.C. Allergy and anaphylaxis in anaesthesia. Minerva Anestesiol 70 5 (2004) 285-291
73. Laroche D., Dubois F., Gérard J., et al. Radioimmunoassy for plasma histamine: a study of false positive and false negative values. Br J Anaesth 74 (1995) 430-437
74. Fisher M.M., and Baldo B.A. Mast cell tryptase in anaesthetic anaphylactoid reactions. Br J Anaesth 80 1 (1998) 26-29
75. Baldo B.A., and Fisher M.M. Anaphylaxis to muscle relaxant drugs: cross-reactivity and molecular basis of binding of IgE antibodies detected by radioimmunoassay. Mol Immunol 20 12 (1983) 1393-1400
76. Fisher M.M., and Baldo B.A. Immunoassays in the diagnosis of anaphylaxis to neuromuscular blocking drugs: the value of morphine for the detection of IgE antibodies in allergic subjects. Anaesth Intensive Care 28 (2000) 167-170
77. Gueant J.L., Mata E., Monin B., et al. Evaluation of a new reactive solid phase for radioimmunoassay of serum specific IgE against muscle relaxant drugs. Allergy 46 6 (1991) 452-458
78. Guilloux L., Ricard-Blum S., Ville G., et al. A new radioimmunoassay using a commercially available solid support for the detection of IgE antibodies against muscle relaxants. J Allergy Clin Immunol 90 2 (1992) 153-159
79. Ebo D.G., Venemalm L., Bridts C.H., et al. Immunoglobulin E antibodies to rocuronium: a new diagnostic tool. Anesthesiology 107 2 (2007) 253-259
80. Baldo B.A., Fisher M.M., and Harle D.G. Allergy to thiopentone. Clin Rev Allergy 9 3-4 (1991) 295-308
81. Fisher M.M., Harle D.G., and Baldo B.A. Anaphylactoid reactions to narcotic analgesics. Clin Rev Allergy 9 3-4 (1991) 309-318
82. Gueant J.L., Mata E., Masson C., et al. Non-specific cross-reactivity of hydrophobic serum IgE to hydrophobic drugs. Mol Immunol 32 4 (1995) 259-266
83. Hemery M.L., Arnoux B., Rongier M., et al. Correlation between former and new assays of latex IgE-specific determination using the K82 and K82 recombinant allergens from the Pharmacia Diagnostics laboratory. Allergy 60 1 (2005) 131-132
84. Soetens F.M. Anaphylaxis during anaesthesia: diagnosis and treatment. Acta Anaesthesiol Belg 55 3 (2004) 229-237
85. Fisher M.M., Merefield D., and Baldo B. Failure to prevent an anaphylactic reaction to a second neuromuscular blocking drug during anaesthesia. Br J Anaesth 82 5 (1999) 770-773
86. Levy J.H., Gottge M., Szlam F., et al. Weal and flare responses to intradermal rocuronium and cis-atracurium in humans. Br J Anaesth 85 (2000) 844-849
87. Berg C.M., Heier T., Wilhelmsen V., et al. Rocuronium and cisatracurium-positive skin tests in non-allergic volunteers: determination of drug concentration thresholds using a dilution titration technique. Acta Anaesthesiol Scand 47 5 (2003) 576-582
88. Thacker M.A., and Davis F.M. Subsequent general anaesthesia in patients with a history of previous anaphylactoid/anaphylactic reaction to muscle relaxant. Anaesth Intensive Care 27 2 (1999) 190-193
89. Laxenaire M.C., and Moneret-Vautrin D.A. Allergy and anaesthesia. Curr Opin Anaesthesiol 5 (1992) 436-441
90. Leynadier F., Sansarricq M., Didier J.M., et al. Prick tests in the diagnosis of anaphylaxis to general anaesthetics. Br J Anaesth 59 6 (1987) 683-689
91. Fisher M.M., and Bowey C.J. Intradermal compared with prick testing in the diagnosis of anaesthetic allergy. Br J Anaesth 79 1 (1997) 59-63
92. McKinnon R.P. Allergic reactions during anaesthesia. Curr Opin Anaesthesiol 9 (1996) 267-270
93. Moneret-Vautrin D.A., and Laxenaire M.C. Skin tests in diagnosis of allergy to muscle relaxants and other anaesthetic drugs. In: Assem E.S. (Ed). Allergic reactions to anaesthetics: clinical and basic aspects vol. 30 (1992), Karger, Basel 145-155
94. Turjanmaa K., Palosuo T., Alenius H., et al. Latex allergy diagnosis: in vivo and in vitro standardization of a natural rubber latex extract. Allergy 52 1 (1997) 41-50
95. Mata E., Gueant J.L., Moneret-Vautrin D.A., et al. Clinical evaluation of in vitro leukocyte histamine release in allergy to muscle relaxant drugs. Allergy 47 5 (1992) 471-476
96. Gueant J.L., Masson C., and Laxenaire M.C. Biological tests for diagnosing the IgE-mediate allergy to anaesthetic drugs. In: Assem K. (Ed). Monographs in allergy (1992), Karger, Basel 94-107
97. Bermejo N., Guéant J., Mata E., et al. Platelet serotonin is a mediator potentially involved in anaphylactic reaction to neuromuscular blocking drugs. Br J Anaesth 70 3 (1993) 322-325
98. Assem E. Release of eosinophil cationic protein (ECP) in anaphylactoid anaesthetic reactions in vivo and in vitro. Agents Actions 41 (1994) C11-C13
99. Assem E. Leukotriene C4 release from blood cells in vitro in patients with anaphylactoid reactions to neuromuscular blockers. Agents Actions 38 (1993) C242-C244
100. Abuaf N., Rajoely B., Ghazouani E., et al. Validation of a flow cytometric assay detecting in vitro basophil activation for the diagnosis of muscle relaxant allergy. J Allergy Clin Immunol 104 2 Pt 1 (1999) 411-418
101. Sabbah A., Drouet M., Sainte-Laudry J., et al. [Contribution of flow cytometry to allergologic diagnosis]. Allerg Immunol (Paris) 29 1 (1997) 15-21 [in French]
102. Sainte-Laudy J., Vallon C., and Guerin J.C. Analysis of membrane expression of the CD63 human basophil activation marker: applications to allergologic diagnosis. Allerg Immunol (Paris) 26 6 (1994) 211-214
103. Monneret G., Benoit Y., Gutowski M., et al. Detection of basophil activation by flow cytométrie in patients with allergy to muscle-relaxant drugs. Anesthesiology 92 1 (2000) 275-277
104. De Week A.L., Sanz M.L., Gamboa P.M., et al. Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls. II. Technical issues. J Investig Allergol Clin Immunol 18 3 (2008) 143-155
105. [Prévention du risque allergique peranesthésique: recommandations pour la pratique clinique]. Available at:. www.sfar.org Accessed April 15, 2004 [in French]
106. Allombert-Marechal G., Vervloet D., Arnaud A., et al. [Provocation tests to local anesthetics]. Presse Med 13 31 (1984) 1903-1904 [in French]
107. Cremer R., Lorbacher M., Hering F., et al. Natural rubber latex sensitisation and allergy in patients with spina bifida, urogenital disorders and oesophageal atresia compared with a normal paediatric population. Eur J Pediatr Surg 17 3 (2007) 194-198
108. Task Force on Latex Sensitivity. Natural rubber latex allergy: considerations for anesthesiologists (1999), American Society of Anesthesiologists, Park Ridge (IL)
109. Moss J., Roizen M.F., Nordby E.J., et al. Decreased incidence and mortality of anaphylaxis to chymopapain. Anesth Analg 64 12 (1985) 1197-1201
110. Raut C.P., Hunt K.K., Akins J.S., et al. Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol. Cancer 104 4 (2005) 692-699
111. Hedin H., and Ljungstrom K.G. Prevention of dextran anaphylaxis: ten years experience with hapten dextran. Int Arch Allergy Immunol 113 1-3 (1997) 358-359
112. Moneret-Vautrin D.A., Kanny G., Gueant J.L., et al. Prevention by monovalent haptens of IgE-dependent leucocyte histamine release to muscle relaxants. Int Arch Allergy Immunol 107 1-3 (1995) 172-175